Abbreviations: Endo H, endoglycosidase H; ER, endoplasmic reticulum; ERAD, endoplasmic reticulum associated degradation; Kar2 SP, Kar2p signal peptide; RTA, ricin toxin A chain; RTB, ricin toxin B chain.
Summary
Ricin is a heterodimeric plant protein that is potently toxic to mammalian cells. Toxicity results from the catalytic depurination of eukaryotic ribosomes by ricin A chain (RTA) that follows toxin endocytosis to, and translocation across, the endoplasmic reticulum (ER) membrane. To ultimately identify proteins required for these later steps in the entry process, it will be useful to express the catalytic subunit within the ER of yeast cells in a manner that initially permits cell growth. A subsequent switch in conditions to provoke innate toxin action would permit only those strains containing defects in genes normally essential for toxin retro-translocation, refolding or degradation to survive. As a route to such a screen, several RTA mutants with reduced catalytic activity have previously been isolated. Here we report the use of Saccharomyces cerevisiae to isolate temperaturedependent mutants of endoplasmic reticulum-targeted RTA. Two such toxin mutants with opposing phenotypes were isolated. One mutant RTA (RTA F108L/L151P ) allowed the yeast cells that express it to grow at 37°C while the same cells did not grow at 23ºC. Both mutations were required for temperature-dependent growth. The second toxin mutant (RTA E177D ) allowed cells to grow at 23°C but not at 37°C. Interestingly, RTA E177D has been previously reported to have reduced catalytic activity, but this is the first
Introduction
Ricin A chain (RTA) is the catalytic polypeptide of the heterodimeric toxin ricin, which is produced in the endosperm of the seed of the castor bean plant, Ricinus communis. The study of ricin, in particular its route into target cells and the fate of its two subunits, RTA and the cell-binding galactose-specific lectin ricin B chain (RTB), are essential to gain further insights into the mechanism of toxin action [1] .
During intoxication of mammalian cells, ricin is endocytosed to the endoplasmic reticulum (ER) from where the newly reduced A chain is retro-translocated to the cytosol [2] [3] [4] [5] [6] . The mechanism by which the RTA subunit is retro-translocated has not been fully elucidated but is thought to require at least some of the proteins involved in the branch of ER quality control that normally deals with misfolded/conformationally regulated proteins. These latter are detected, exported from the ER and degraded by proteasomes in a tightly coupled process known as ER-associated degradation (ERAD). It appears likely that RTA (and other toxins that reach the ER lumen) may hi-jack components of the ERAD pathway to reach the cytosol where a proportion of toxin can refold to a catalytically-active conformation [6] [7] [8] . The refolded fraction then removes a single adenine residue from the critical sarcin/ricin loop sequence of the 28S, 26S or 25S RNA (rRNA) of eukaryotic ribosomes [9] . This modification irreversibly disrupts the elongation factor-2 (EF-2) binding site [10] , efficiently inhibiting protein synthesis. It is unclear at present whether this leads directly to cell death or whether ribotoxic stress ultimately triggers signal transduction leading to apoptosis [11, 12] .
The budding yeast Saccharomyces cerevisiae has been used to study various cellular mechanisms, and the genetic tractability and ease of culturing has obvious advantages in genetic screens for mutant RTA open reading frames (ORFs) [13] [14] [15] . Although Sc. cerevisiae 25S rRNA molecules are very sensitive to RTA, yeast cells are not susceptible to externally administered ricin since they lack galactosyl transferase [16] . Thus they lack the galactosylated receptors needed to permit ricin uptake (as mentioned above, ricin is a galactose-specific lectin [17] ). It is, however, possible to mimic the final stage in the intoxication process in yeast by directing RTA to the ER using a yeast (in this case, Kar2p) signal peptide (Kar2 SP ) [7] . Using this targeted delivery approach we have already excluded some components of the yeast ERAD pathway as being important for RTA intoxication whilst implicating others [7] .
To gain a more complete inventory of factors required for the entry of ricin A chain to the cytosol it will be useful to express inducible toxin in the ER of mutant strains of yeast, in a manner akin to its expression in plant cells [18] . Survivors of toxin expression may contain defects in genes normally essential for toxin retro-translocation, refolding, degradation or action on ribosomes. Such screens normally require the transformation of yeast libraries with plasmids encoding native ricin A chain whose expression is very tightly regulated. An alternative approach that avoids the need for stringent promoter regulation is the use of toxin variants whose effects on yeast cell growth can be controlled by a simple shift in temperature. In a previous study we have utilized the sensitivity of yeast cells to identify a number of RTA mutants with reduced catalytic activity [15] . Here, we describe the characterisation of a further class of RTA mutants in which the toxins expressed in yeast cells display cold-sensitive and heat-sensitive phenotypes. We believe these temperature-dependent RTA mutants will be useful additions to the range of reagents that can be used in future genetic screens aimed toward identifying yeast components required for ER retro-translocation and cytosolic refolding of ricin.
Results
We used a vector-based RTA ORF fused to the co-translational Kar2p signal sequence (Kar2 SP ) in order to isolate attenuated RTA molecules that had been directed to the ER lumen. Figure 1 shows a schematic that depicts the procedure for gap repair cloning and the selection of temperature-dependent mutants. The gap repair transformation was performed using BglII cut pRS316 Kar2 SP -RTA as the vector together with the product from 5 rounds of error prone, Taq polymerase-based PCR of the entire RTA ORF (see Materials and Methods, and Allen et al., [15] ). Yeast were plated onto selective media at either 37ºC or 23°C respectively and allowed to grow for 16 hours before they were replica plated and grown at alternative temperatures (23ºC or 37°C respectively). Isolates growing at both temperatures were ignored whilst isolates growing only at one of the temperatures (termed permissive, where the expression of toxin did not inhibit cell growth) were picked and further screened. To further analyse these isolates, plasmid DNA was extracted, purified and sequenced to determine the nature of the mutations.
Any mutations discovered were remade in the wild-type Kar2 SP -RTA plasmid before retesting and validating the effects on cell growth by transforming W303.1C and plating the cells at 23ºC, 30ºC and 37ºC.
A cold-sensitive growth phenotype (where toxin is active and interferes with cell growth only at low temperature) was isolated from cells expressing RTA in which Phe108 was converted to Leu (specified by the point mutation T322C), and Leu151 was converted to Pro (specified by the point mutation T452C). Base numbers relate to the published RTA coding sequence [19] . These two amino acid substitutions were individually introduced into a wild-type RTA plasmid but temperature-dependent growth of transformants was no longer observed ( Fig. 2A) . In contrast, a heat-sensitive growth phenotype (where toxin is active and interferes with cell growth only at a high temperature) was isolated from cells expressing RTA with point mutation A531 to C, which converted the active site Glu177 to Asp (Fig. 2A) . This particular mutant (RTA E177D ) has previously been described as having reduced catalytic activity [13, 20] , although its temperature-dependence was not investigated. To confirm that yeast cells were able to grow at all temperatures when expressing a known inactive RTA variant, Kar2 SP -RTAΔ was utilized in which key active site residues are missing [7] . Interestingly, when the double mutant is expressed in the cytosol without a signal peptide, the yeast cells grow at 37ºC only (Fig. 2B ). The growth pattern is similar to that of RTA F108L/L151P when targeted to the ER ( Fig. 2A ) although no growth is ever observed at 30ºC. This demonstrates that the cold-sensitive growth phenotype seen in this yeast strain genuinely reflects of the sensitivity of the mutant toxin to temperature.
To obtain a clearer picture of the growth profiles of yeast cells expressing these RTAs, cells were plated at various temperatures as illustrated in Figure 3A . Yeast cells expressing Kar2 SP -RTA F108L/L151P were unable to grow at temperatures below 25°C. For cells expressing Kar2 SP -RTA E177D , growth was observed at all temperatures with the exception of 37°C. In contrast, the Kar2 SP -RTAΔ variant showed comparable growth at all temperatures. The growth profiles of Kar2 SP -RTA E177D at 30ºC and 37ºC, and Kar2 SP -RTA F108L/L151P at 23ºC and 37ºC, were validated in liquid cultures with time courses confirming the predicted phenotypes (Fig. 3B) . However, neither of the temperaturedependent RTA variants was lethal since the cells expressing them were fully viable when returned to the respective permissive temperature (Fig. 3C) . Indeed, when RTAexpressing cells were maintained at temperatures restrictive for growth for more than 72 hours, they were fully viable when shifted back to the respective permissive temperature (data not shown).
We next sought to determine the in vivo catalytic activities (i.e. the ability to depurinate were grown for approximately 24 hours at the permissive temperatures of 30°C and 37°C, respectively. A sample of the cells was removed from each culture, rRNAs were isolated in Trizol, and the extent to which they had been depurinated by active toxin in vivo determined (this is designated as time 0 in Fig. 4 ). The remainder of each culture was divided into two, with one half being incubated at the permissive temperature for a further 24 hours while the other half was incubated at the non-permissive temperature for the same period. Toxin-mediated damage to ribosomes renders the depurinated site highly labile to hydrolysis by acetic-aniline. Therefore, each sample of isolated rRNA was treated with acetic-aniline and separated on a denaturing gel before blotting to detect Figure 5 shows that the different RTA variants were indeed expressed at all temperatures and that they efficiently reached the ER lumen, as judged by glycosylation and signal peptide removal. Digestion with Endoglycosidase H (Endo H) confirmed that the higher molecular weight forms were N-glycosylated. RTAΔ, which is completely devoid of catalytic activity, was more extensively N-glycosylated than RTA E177D , most likely because RTAΔ cannot fold correctly, prolonging exposure of its glycosylation sequons to oligosaccharyl transferase. Interestingly RTA F108L/L151P , which retains some catalytic activity at the temperature permissive for cell growth, displayed a similar N-glycosylation profile to RTAΔ, again indicating some difficulty in assuming a tightly folded conformation. By contrast, RTA E177D is mainly non glycosylated with only a minor fraction carrying a single glycan. This is more typical of a toxin that rapidly assumes its folded conformation (our unpublished observations). The deglycosylated RTAs (Fig. 5, agrees with previously published data with respect to its disappearance at 30ºC, and is consistent with the retro-translocation of this protein to the cytosol where a proportion is degraded by proteasomes [7] . Although more protein is synthesised during the short pulse at 37°C (Fig 6A; 37°C , zero chase point), it is evident that some protein turnover occurred at all the temperatures assayed ( Fig. 6A ). In contrast, visual inspection revealed that retro-translocated RTA F108L/L151P disappeared most markedly at 23°C while it appeared completely stable at 37°C (Fig. 6B ). Stability was observed at the higher temperature when this protein was expressed either by the ER lumen or directly in the cytosol without a signal peptide. Such apparent stability may provide an explanation as to why yeast cells can tolerate expression and persistence of this protein under these conditions, as it may misfold at the higher temperature to yield an inactive, proteaseresistant aggregate.
We attempted to obtain the X-ray crystallographic structures of the temperaturedependent RTA variants. Despite repeated attempts using Escherichia coli as the expression host at a variety of temperatures, we were unable to purify the necessary amount of RTA F108L/L151P . By contrast, recombinant RTA E177D was readily purified from bacteria and shown to depurinate yeast ribosomes in vitro when assayed at either 30°C or 37°C. Figure 7A shows denaturing gels of aniline-treated rRNA extracted from purified yeast ribosomes that had been treated with decreasing doses of RTA E177D at 30ºC and 37ºC. Acetic-aniline will only hydrolyse the phosphoester bond at a depurinated site (such as the site in rRNA that becomes modified by toxin). This releases a small fragment of 25S rRNA that is readily visible on gels, migrating between the larger and smaller intact rRNA species. The released fragments were quantified relative to 5.8S rRNA to control for differences in gel loading, and the percentage of depurinated rRNA was determined at different RTA E177D concentrations [20] . Not unexpectedly, at low RTA E177D
concentrations, the rate of depurination was faster at 37°C than at 30°C (Fig. 7B ). The in vitro DC 50 (the amount of protein required to depurinate 50% of the ribosomes) also decreased with temperature from 486ng at 30°C to 209ng at 37°C. This increased depurination at higher temperatures would explain the inability of yeast cells expressing RTA E177D to grow at 37°C.
Purified recombinant RTA E177D was crystallised and its structure determined (Fig. 8 ).
Compared to wild-type RTA, the E177D mutation resulted in a side-chain shortened by a methylene group, which slightly altered the position of the salt-bridged Arg180. This subtle conformational change disrupts the close contact between Arg180 and Tyr80 observed in the wild-type structure, forcing the Tyr80 side-chain to move slightly leaving it more exposed to solvent and breaking the hydrogen bond between the hydroxyl group of Tyr80 and the Gly121 carbonyl oxygen (Fig. 8 , compare A and B with C). These changes are very slight but since they involve active site residues, they impact on toxin activity. In our first experiment we followed the optimized crystallisation conditions of Weston et al. [22] , which resulted in an acetate ion bound (salt-bridged) to Arg180 and sandwiched between the aromatic rings of Tyr80 and Tyr123 close to the single point mutation site of E177D (Fig. 8A ). We then replaced acetate in the crystallisation mother liquor with citrate, which gave a virtually identical side-chain arrangement surrounding the mutation site ( 
Discussion
RTA is the catalytic polypeptide of the heterodimeric toxin ricin. After binding to target mammalian cells, ricin is endocytosed to the ER lumen where toxin reduction and subunit retro-translocation to the cytosol occurs. This reverse translocation is believed to require an unfolded/partially folded protein that, in the case of RTA, may occur through exposure of a C-terminal hydrophobic domain upon reduction. On the cytosolic side of the membrane, a proportion of RTA must refold so that it can inactivate ribosomes by depurination [10] . Ribosomes modified in this way are no longer capable of synthesising proteins, and when an appropriate proportion of the total cellular ribosome pool has been depurinated, protein synthesis is insufficient for viability leading either directly to cell death or by triggering apoptotic pathways. Although much is known about the trafficking of toxins, a lot less is known about these downstream steps of cell intoxication.
Experimental evidence pertinent to this question is patchy at present, but the emerging picture indicates that toxins like ricin can exploit an unknown number of ER and membrane components normally involved in perceiving and extracting proteins from the ER to the cytosol [23] . In order to ultimately identify the complete repertoire of molecules involved, we have generated and characterised two temperature-dependent RTA mutants from yeast. These will be utilized in subsequent screens for yeast genes important for the cytosolic entry of ricin A chain.
We have previously reported a novel mechanism for gap repair cloning in Sc. cerevisiae that can be used to generate mutations only within the RTA ORF. This was verified by the detection of either glycosylated or non-glycosylated but signal peptide-cleaved forms (Fig. 5) . Subsequent retro-translocation of these RTAs would be predicted to result in ribosome modification, which if excessive, would lead to cell intoxication and death. However, the precise outcome would depend on a number of factors, not least the available pool of unmodified ribosomes.
Yeast cells shifted to higher temperatures may have a smaller population of ribosomes.
Indeed, it has been reported that yeast cells switched to 37ºC show a dramatic decrease in ribosomal protein transcription within the first 20 minutes. However, the normal rate of ribosome synthesis is resumed within the hour [24, 25] . We therefore postulate that the reduced ability of yeast to grow whilst remaining viable after incubation at 37ºC, is not simply a reflection of a smaller pool of ribosomes. However, the balance between the number of functional ribosomes required for cells to grow and the number of ribosomes inactivated by toxin must be critical. We deduce that when cells expressing RTA E177D are incubated at 37°C, more RTA protein is made (Fig. 5 ) and the enzyme is sufficiently active (Fig. 4) to depurinate enough ribosomes to inhibit cell growth ( Fig. 2A) . However, in contrast to the lethality observed with native RTA [15] , it is important to reiterate that cells expressing RTA E177D at 37°C remain viable and resume growth when returned to a lower temperature (Fig. 3C) , supporting the contention that in this case, it is the proportion of active ribosomes required for growth that is critical. Indeed, Gould et al., [14] reported that yeast could tolerate ~20% ribosome inactivation, while the present study indicates that in the yeast strain used here, only a depurination level greater than ~35% was detrimental and prevented growth (Fig. 4) . It should be noted that the mechanism of growth arrest seen here is not known with certainty.
RTA E177D has previously been shown to be ~50-fold less catalytically active than wildtype RTA [20] . As such, it is often used in experiments where the toxin needs to be visualised in the absence of cell death [18, 21, 26] . In an attempt to establish a structural basis for this reduction in activity, we have now solved the X-ray crystallographic structure of RTA E177D to 1.6Å resolution. A comparison of the mutant RTA structure with that of wild-type RTA [22] shows that the two structures are essentially identical apart from some subtle side-chain realignments in the region of the active site (Fig. 8 ). These realignments in RTA E177D must account for its reduced catalytic activity. However, it is important to note that the structure is essentially native. This finding will be particularly pertinent for studies of RTA retro-translocation where a protein with reduced activity but with as near native a structure as normal is required. The solved structure of RTA E177D
will deflect concerns that a mutant, and by inference a structurally-defective variant, is being used to probe events relating to the behaviour of a native polypeptide.
The novel RTA F108L/L151P isolated in the present study allows yeast to grow above ~25°C
but not at lower temperatures (Figs. 3A and B) . However, significantly less RTA F108L/L151P was produced at 23°C -when the cells failed to grow, than at 37°C when cells grew normally ( Fig. 5 and Fig. 6B zero chase points). We propose that the most likely explanation for this curious observation is that while ER-targeted RTA F108L/L151P
retro-translocates to the cytosol at 23°C where a fraction can damage ribosomes even though the bulk will be targeted for proteasomal degradation, this mutant toxin aggregates at 37°C to a non-active, protease-resistant species. Consistent with this, upon pulse-chase, both glycosylated and non glycosylated RTA F108L/L151 appeared completely stable at 37°C, in contrast to their behaviour at lower temperatures (Fig. 6B ). Cells expressing a version without an ER signal peptide also grew at 37°C (Fig. 2B ) and the cytosolic protein similarly persisted with time at this temperature ( Fig.6B; cRTA F108L/L151P ), indicating a general (rather than an ER-specific) propensity to misfold, aggregate and resist turnover at the higher temperature.
We report that RTA F108L/L151P required both substitutions for yeast cells to exhibit temperature-dependent growth. RTAs carrying the equivalent single amino acid substitutions behaved like wild type RTA in that transformed cells failed to grow at any of the temperatures tested ( Fig. 2A) . In contrast, when both point mutations were simultaneously introduced into a wild type RTA ORF, transformants were once again cold-sensitive for growth. We attempted to obtain the X-ray crystallographic structures of the single and double RTA F108L/L151P , but repeatedly failed to purify appropriate amounts following expression in E. coli. It is possible this protein has a tendency to be unstable in E. coli and hence is difficult to express in large amounts. Some difficulty in assuming a folded conformation is indicated by the N-glycosylation pattern of this protein in yeast (Fig. 5 , compare the glycan pattern of RTA F108L/L151P with the efficiently glycosylated but misfolded RTAΔ and the under-glycosylated but near-native RTA E177D ) and the finding of an apparently stable (we propose, aggregated) species when expressed in yeast at the higher temperature. Nevertheless, there is clearly activity associated with RTA F108L/L151P , which implies the protein can be folded correctly when it is expressed at temperatures below 28°C (Fig. 3A, Fig. 4B ).
The striking switch of growth versus no growth observed when both RTA F108L/L151P and RTA E177D are expressed at different temperatures provides a simple and effective way of screening for yeast genes that perturb the cytosolic entry, degradation or refolding of ricin.
Furthermore, it circumvents the need to use tightly regulated promoters to maintain cell growth in the presence of plasmids carrying a native RTA coding sequence to such time that induction of expression is required. Such promoters can be variously leaky, with consequent lethality when native ricin A chain is being made [14] . Although beyond the scope of the present study, it now remains for such proteins to be utilized in yeast genetic screens and for their behaviour to be fully characterised in mammalian and plant systems.
Experimental Procedures
Yeast strain, manipulations and growth media. uracil (AA-ura) as previously described [7] . Yeast transformations were achieved by using the lithium acetate/single stranded DNA/PEG method as previously described [28] .
Cultures of
The expression of Kar2 SP -RTA wild type and mutant ORFs from the pRS316 vectors was under the control of the GAPDH promoter and the PHO5 terminator as previously described [7] .
PCR mutagenesis.
RTA variants were generated by multiple rounds of error-prone PCR using Taq DNA polymerase (Invitrogen) as described previously [15] . Oligonucleotide primers used to amplify the mature ORF of RTA were CP172 5'-ATATTCCCCAAACAATACCC-3' and the antisense primer CP133 5'-TTAAAACTGTGACGATGGTGGA-3' with the TAA termination anti-codon shown in bold. Amplification reactions were performed in a final volume of 50 µl containing 5 ng of template DNA according to the manufacturer's instructions. The final PCR product was purified using a QIAquick Gel Extraction Kit (Qiagen) according to the manufacture's protocol, and quantified by determining the absorbance at 260 nm and used directly in yeast transformations.
Yeast plating.
Yeast cultures were grown overnight at the permissive temperatures in liquid media. To ensure an even number of colonies per plate, the cultures were diluted to 4x10 4 cells ml -1 , before 1x10 4 cells were plated onto AA-ura agar. Plates were incubated at the appropriate temperature for various times until colonies of similar sizes were formed.
Pulse-chase analyses.
Pulse-chase experiments were performed as described previously [7] . Briefly, 3.7 x10 and RTA immunoprecipitated from cell lysates as described previously [7] . and grown overnight at 37ºC. This culture was used to inoculate 500 ml of 2YT, and the culture was grown for 2 h at 30ºC. Expression was induced by adding isopropyl thio-β-Dgalactoside to a final concentration of 0.1 mM for 4 h at 30ºC. Cells were harvested by low speed centrifugation, resuspended in 15 ml of 5 mM sodium phosphate buffer (pH 6.5), and lysed by sonication on ice. Cell debris was pelleted by centrifugation at 31,400 g at 4ºC for 30 min and the supernatant loaded onto a 50 ml CM-Sepharose CL-6B column (Amersham Biosciences). The column was washed with 1 l of 5 mM sodium phosphate (pH 6.5) followed by 100 ml of 100 mM NaCl in 5 mM sodium phosphate (pH 6.5) and RTA E177D was eluted with a linear gradient of 100-300 mM NaCl in the same buffer.
Endoglycosidase H treatment.

Radiolabelled immunoprecitates bound to Protein
Fractions containing RTA E177D were pooled and stored at 4ºC at a concentration of 1 mg/ml.
Crystallisation, X-ray data collection and refinement of RTA E177D .
Crystals were grown in the tetragonal space group P41212 by the sitting-drop method using microbridges (Crystal Microsystems, UK) and the conditions described for wildtype RTA crystallisation [22] and also under conditions where citrate buffer was substituted for acetate buffer. Data were collected at 100 K using 15% (v/v) glycerol as a cryoprotectant and processed using the HKL suite of programs [33] . Refinement of the Table 1 .
RNA extraction.
Yeast cells expressing RTA were grown at either permissive or non-permissive temperatures before being harvested and resuspended in Trizol (Invitrogen) prior to lysis.
RNA from 5 x 10 7 cells was extracted using standard techniques [37] .
In vitro depurination of salt washed ribosomes. 
